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We read with interest the report by Akinosoglou et al. [1] on the
surgical management of tricuspid valve infective endocarditis.
We congratulate the authors for their excellent and extensive
review of the literature and for providing useful management
algorithms. We would like to discuss biodegradable materials in
this patient group.
The authors divide the surgical techniques into non-prosthetic
and prosthetic. However, there exists an intermediate option,
which is not mentioned: the emerging role of biodegradable
materials in valve repair.
Annuloplasty plays an important role in valve reconstruction,
particularly if a signiﬁcantly infected leaﬂet segment must be
resected to relieve tension on the repaired leaﬂets. We have
used a biodegradable annuloplasty ring, which is inserted suben-
docardially, dissolves and is replaced by autologous ﬁbrous
tissue [2]. This might represent an advantage for this speciﬁc
patient population, due to the lack of blood contact and absorb-
able ring material. We have previously reported our experience
using this ring in patients with acute infective endocarditis [3, 4].
Furthermore, the authors discuss patch reconstruction of deb-
rided leaﬂets, but do not review the available materials and their
relative beneﬁts in endocarditis. We are particularly interested in
extracellular matrix scaffolds (such as CorMatrix©) for the repair
of large leaﬂet defects, as these patches are intended to be
replaced by autologous tissue [5].
These evolving biodegradable devices, from annuloplasty rings
to patch materials, offer the potential for valve repair with de-
gradable materials replaced with autologous tissue, which could
further improve the results of valve repair for infective endocar-
ditis. Long-term results are lacking and further data are necessary
to validate this theoretically interesting approach to infective
endocarditis.
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